As one might guess from reading this space, I always have an itch to try new sequencing technologies or updates to existing ones. That's generally a good thing in my position, though more than a few times I experience buyers remorse. At least this time, I found something a bit interesting
A computational biologist's personal views on new technologies & publications on genomics & proteomics and their impact on drug discovery
Monday, January 14, 2013
Thursday, January 10, 2013
As the clear leader in the genome sequencing technology market, Illumina is often in the news. As befitting the winter season, there's just been a blizzard of Illumina news, mostly announcements from within but also two important external ones (an excellent summary of these can be found at NextGenSeek).
Subscribe to: Posts (Atom)